← Back to Clinical Trials
Recruiting Phase 3 NCT03902912

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Recurrent Miscarriage
Sponsor Chinese University of Hong Kong
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 84
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2019-07-30
Completion 2027-04-30
Interventions
Prednisolone

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to investigate the role of uNK cells and the association with prednisolone.

Eligibility Criteria

Inclusion Criteria: 1. Women with a history of 3 or more consecutive miscarriages 2. Women younger than 40 years old Exclusion Criteria: 1. Allergy to prednisolone 2. Women who have any uterine anomaly 3. Antiphospholipid syndrome 4. Hydrosalpinx 5. Thrombophilia 6. Abnormal thyroid function tests 7. women with diabetes,

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE RECURRENT MISCARRIAGE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}